Details for New Drug Application (NDA): 206250
✉ Email this page to a colleague
The generic ingredient in VENLAFAXINE HYDROCHLORIDE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Summary for 206250
Tradename: | VENLAFAXINE HYDROCHLORIDE |
Applicant: | Cadila Pharms Ltd |
Ingredient: | venlafaxine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 206250
Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 206250
Suppliers and Packaging for NDA: 206250
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 206250 | ANDA | Cadila Pharmaceuticals Limited | 71209-025 | 71209-025-05 | 100 TABLET in 1 BOTTLE (71209-025-05) |
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 206250 | ANDA | Cadila Pharmaceuticals Limited | 71209-026 | 71209-026-05 | 100 TABLET in 1 BOTTLE (71209-026-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Nov 21, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 37.5MG BASE | ||||
Approval Date: | Nov 21, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Nov 21, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription